ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 426

Dickkopf-1 Stimulates Fibroblast-Like Synoviocyte Migration Through Janus Kinase Activation

Yubin Luo1, Bryan Dieffenbach2, Jung-Soo Song3, Jinseok Kim4, David L. Boyle5, Michael Karin6, Gary S. Firestein7 and Maripat Corr8, 1Medicine, UCSD School of Medicine, La Jolla, CA, 2Medicine, UCSD School of Medicine, la Jolla, CA, 3Rheumatology, Chung-Ang University College of Medicine, Seoul, South Korea, 4Division of Rheumatology, Internal Medicine, Jeju National University Hospital, Jeju, Korea, South Korea, 5Div of Rheum, UCSD School of Medicine, La Jolla, CA, 6Departments of Pharmacology, UCSD School of Medicine, La Jolla, CA, 7Div of Rheumatology, UCSD School of Medicine, La Jolla, CA, 8Medicine, Univ of California-San Diego, La Jolla, CA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenisis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Wnt (wingless) pathway signaling has been implicated in patterning in embryogenesis and in adult wound healing and homeostasis. A canonical Wnt antagonist, Dickkopf-1 (DKK-1), has been described as an embryonic bone morphogen. DKK-1 expression is stimulated by TNF in inflammatory disease and is elevated in the sera of rheumatoid arthritis patients.  This Wnt signaling antagonist has been linked to the depression osteoblast activity and bone loss. Here we examined a novel role for the pathogenic activity of this protein by virtue of its ability to activate JNK and increase migration of fibroblast-like synoviocytes (FLS).

Methods:

Human and mouse FLS were cultured and the plates were scratched. Migration was measured by serial photography of a marked area and Image J quantification.  Results were confirmed with an Oris™ stopper assay, and cell entry into the central clearing was measured by calcein AM fluorescence. FLS were treated with rDKK-1, rWnt5a, PDGF, SB216763 (a GSK3ß inhibitor), SP600125 (a JNK inhibitor), and IWP-2 (a porcupine inhibitor). In some cases, FLS were lysed for Western blot and qPCR analyses.

Results: 

Human and mouse FLS exhibited faster migration in the scratch wound assay and the stopper assay when stimulated with DKK-1 (50, 100 or 150ng/ml). DKK-1 increased percent wound closure from 31+4to 46+5 (p<0.04) for human and 41+4 to 58+18 (p<0.04) for mouse FLS.  DKK-1-induced migration was inhibited by the JNK inhibitor SP600125. On the other hand, SB216763 and IWP-2 had minimal or no effect, indicating that it is independent of endogenously produced Wnt.  DKK-1 stimulated JNK phosphorylation in FLS within 10 minutes, which was also not abrogated by IWP-2.  To determine which JNK isoform is responsible, JNK1 null and JNK2 null mouse FLS were studied in the migration assays. Unexpectedly, DKK-1 treatment still induced the migration of JNK1 deficient, but not JNK2 deficient cells. In association with increased migration, DKK-1 treated FLS increased expression of MMP-1 (1.4 fold), MMP2 (1.4 fold) and MMP13 (1.6 fold). In contrast, MMP9 and MMP3 expression was decreased.

Conclusion: DKK-1 stimulates migration of FLS, which is associated with JNK phosphorylation and increased expression of selected metalloproteinases. DKK-1-induced migration was mediated by JNK2 signaling, suggesting that this pathway plays a critical role in synoviocyte migration and cartilage damage in rheumatoid arthritis


Disclosure:

Y. Luo,
None;

B. Dieffenbach,
None;

J. S. Song,
None;

J. Kim,
None;

D. L. Boyle,
None;

M. Karin,
None;

G. S. Firestein,
None;

M. Corr,

arthritis foundation NIH,

2,

UCSD,

3.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dickkopf-1-stimulates-fibroblast-like-synoviocyte-migration-through-janus-kinase-activation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology